Dickerson RD, Putman MJ, Black ME, Pinto KR, Diamond NG, Marynick S, Pinto AB. Selective ovarian vein sampling to localize a Leydig cell tumor. Fertil Steril 2005;84(1):218.

Oncology, Hematology and Oncological Surgery

Baron F, Maris MB, Storer BE, Sandmaier BM, Stuart MJ, McSweeney PA, Radich JP, Pulsipher MA, Agura ED, Chauncey TR, Maloney DG, Shizuru JA, Storb R. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia. Biol Blood Marrow Transplant 2005;11(4):272–279.

Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, Zhang Y, Mhashilkar A, Parker K, Vukelja S, Richards D, Hood J, Coffee K, Nemunaitis J. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther 2005;11(1):149–159.

Eager R, Nemunaitis J. GM-CSF gene-transduced tumor vaccines. Mol Ther 2005;12(1):18–27.

Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O'Shaughnessy J. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 2005;23(31):7794–7803.

Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu MC, Martin M, Namer M, O'Shaughnessy JA, Shen ZZ, Albain KS. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 2005;6(5):391–401.

Howell A, Pippen J, Elledge RM, Mauriac L, Vergote I, Jones SE, Come SE, Osborne CK, Robertson JF. Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trials. Cancer 2005;104(2):236–239.

Hutson TE. Renal cell carcinoma: diagnosis and treatment, 1994–2003. Proc (Bayl Univ Med Cent) 2005;18(4):337–340.

Hutson TE, Bukowski RM. Carcinoma of unknown primary. In McLain RF, ed. Cancer in the Spine: Comprehensive Care. Totowa, NJ: Humana Press, 2005.

Hutson TE, Bukowski RM. Cytokines in renal cell cancer. In Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FM, Linehan WM, eds. Comprehensive Textbook of Genitourinary Oncology, 3rd ed. Baltimore: Lippincott Williams & Wilkins, 2005.

Hutson TE, Quinn D. Cytokine therapy: the standard of care in metastatic RCC? Clinical Genitourinary Cancer 2005;4(3):181–186.

Jones SE. The emergence of aromatase inhibitors/inactivators in early-stage breast cancer: update from the 2004 San Antonio Breast Cancer Symposium. Cancer Abstracts and Summaries 2005;6(4):1–2.

Jones SE, Marty M. Docetaxel versus paclitaxel: head-to-head. Hospital Pharmacy Europe 2005(November/December):17–18.

Jones SE, Pippen J. Effectiveness and tolerability of fulvestrant in postmenopausal women with hormone receptor-positive breast cancer. Clin Breast Cancer 2005;6(Suppl 1):S9–S14.

Kelloff GJ, Hoffman JM, Johnson B, Scher HI, Siegel BA, Cheng EY, Cheson BD, O'Shaughnessy J, Guyton KZ, Mankoff DA, Shankar L, Larson SM, Sigman CC, Schilsky RL, Sullivan DC. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 2005;11(8):2785–2808.

Kelloff GJ, Krohn KA, Larson SM, Weissleder R, Mankoff DA, Hoffman JM, Link JM, Guyton KZ, Eckelman WC, Scher HI, O'Shaughnessy J, Cheson BD, Sigman CC, Tatum JL, Mills GQ, Sullivan DC, Woodcock J. The progress and promise of molecular imaging probes in oncologic drug development. Clin Cancer Res 2005;11(22):7967–7985.

Kerbauy FR, Storb R, Hegenbart U, Gooley T, Shizuru J, Al-Ali HK, Radich JP, Maloney DG, Agura E, Bruno B, Epner EM, Chauncey TR, Blume KG, Niederwieser D, Sandmaier BM. Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML. Leukemia 2005;19(6):990–997.

Konduri K, Sahota SS, Babbage G, Tong AW, Kumar P, Newman JT, Stone MJ. Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression. Clin Lymphoma 2005;5(4):285–289.

Lebedeva IV, Sauane M, Gopalkrishnan RV, Sarkar D, Su ZZ, Gupta P, Nemunaitis J, Cunningham C, Yacoub A, Dent P, Fisher PB. mda-7/IL-24: exploiting cancer's Achilles' heel. Mol Ther 2005;11(1):4–18.

Mamlouk K, Saracino G, Berryman RB, Fay JW, Pineiro LA, Vance EA, White M, Sandler I, Agura ED. Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring. Bone Marrow Transplant 2005;35(8):747–754.

Nemunaitis J. Vaccines in cancer: GVAX, a GM-CSF gene vaccine. Expert Rev Vaccines 2005;4(3):259–274.

Nemunaitis J, Adams N, Cunningham C, Senzer N, Graham S, Barrera D, Nugent J, Stewart C. Phase I trial of an all-oral combination chemotherapy regimen: topotecan and capecitabine in solid tumor patients. J Oncol Manag 2005;14(3):77–90.

Nemunaitis J, Cunningham C, Senzer N, Gray M, Oldham F, Pippen J, Mennel R, Eisenfeld A. Phase I study of CT-2103, a polymer-conjugated paclitaxel, and carboplatin in patients with advanced solid tumors. Cancer Invest 2005;23(8):671–676.

Nemunaitis J, Eiseman I, Cunningham C, Senzer N, Williams A, Lenehan PF, Olson SC, Bycott P, Schlicht M, Zentgraff R, Shin DM, Zinner RG. Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer. Clin Cancer Res 2005;11(10):3846–3853.

O'Brien SM, Cunningham CC, Golenkov AK, Turkina AG, Novick SC, Rai KR. Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia. J Clin Oncol 2005;23(30):7697–7702.

O’Shaughnessy J. Extending survival with chemotherapy in metastatic breast cancer. Oncologist 2005;10(Suppl 3):20–29.

O'Shaughnessy JA, Clark RS, Blum JL, Mennel RG, Snyder D, Ye Z, Liepa AM, Melemed AS, Yardley DA. Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer. Clin Breast Cancer 2005;6(2):143–149.

O'Shaughnessy JA, Vukelja SJ, Holmes FA, Savin M, Jones M, Royall D, George M, Von Hoff D. Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clin Breast Cancer 2005;5(6):439–446.

Price N, Sartor O, Hutson TE, Mariani S. Role of 5a-reductase inhibitors and selective estrogen receptor modulators as potential chemopreventive agents for prostate cancer. Clinical Prostate Cancer 2005;3(4):211–214.

Reddy GK, Gibson TB, Hutson TE, Mariani S, Sartor O. Highlights from the 2005 American Society of Clinical Oncology Prostate Cancer Symposium. Clinical Prostate Cancer 2005;3(4):206–210.

Robertson JF, Come SE, Jones SE, Beex L, Kaufmann M, Makris A, Nortier JW, Possinger K, Rutqvist LE. Endocrine treatment options for advanced breast cancer—the role of fulvestrant. Eur J Cancer 2005;41(3):346–356.

Scruggs RP III, Reynolds J, Garrett CJ. Cancer registry statistics for cancer patients treated at Baylor University Medical Center. Proc (Bayl Univ Med Cent) 2005;18(1):65–67.

Senzer N, Shen Y, Hill C, Nemunaitis J. Individualised cancer therapeutics: dream or reality? Expert Opin Ther Targets 2005;9(6):1189–1201.

Shen Y, Nemunaitis J. Fighting cancer with vaccinia virus: teaching new tricks to an old dog. Mol Ther 2005;11(2):180–195.

Shen Y, Senzer N, Nemunaitis J. Individualised cancer therapeutics: dream or reality? Therapeutics construction. Expert Opin Biol Ther 2005;5(11):1427–1441.

Sorror ML, Maris MB, Sandmaier BM, Storer BE, Stuart MJ, Hegenbart U, Agura E, Chauncey TR, Leis J, Pulsipher M, McSweeney P, Radich JP, Bredeson C, Bruno B, Langston A, Loken MR, Al-Ali H, Blume KG, Storb R, Maloney DG. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. J Clin Oncol 2005;23(16):3819–3829.

Stone MJ, McElroy YG, Pestronk, Reynolds JL, Newman JT, Tong AW. Human monoclonal macroglobulins. DMJ 2005;91(7):278–282.

Tong AW, Nemunaitis J, Su D, Zhang Y, Cunningham C, Senzer N, Netto G, Rich D, Mhashilkar A, Parker K, Coffee K, Ramesh R, Ekmekcioglu S, Grimm EA, van Wart Hood J, Merritt J, Chada S. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther 2005;11(1):160–172.

Tong AW, Zhang YA, Nemunaitis J. Small interfering RNA for experimental cancer therapy. Curr Opin Mol Ther 2005;7(2):114–124.

Verma S, Maraninchi D, O'Shaughnessy J, Jamieson C, Jones S, Martin M, McKendrick J, Miles D, Twelves C, Hornberger J. Capecitabine plus docetaxel combination therapy. Cancer 2005;103(12):2455–2465.

Ophthalmology

Awwad ST, Haithcock KK, Oral D, Bowman RW, Cavanagh HD, McCulley JP. A comparison of induced astigmatism in conventional and wavefront-guided myopic LASIK using LADARVision4000 and VISX S4 platforms. J Refract Surg 2005;21(6):S792–S798.

Awwad ST, Parmar DN, Heilman M, Bowman RW, McCulley JP, Cavanagh HD. Results of penetrating keratoplasty for visual rehabilitation after acanthamoeba keratitis. Am J Ophthalmol 2005;140(6):1080–1084.

Gilliland GD, Gilliland G, Fincher T, Harrington J, Gilliland JM. Assessment of biomechanics of orbital fracture: a study in goats and implications for oculoplastic surgery in humans. Am J Ophthalmol 2005;140(5):868–876.

Li H, Niederkorn JY, Neelam S, Mayhew E, Word RA, McCulley JP, Alizadeh H. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 2005;46(3):900–907.

McCulley JP. Low acute endophthalmitis rate: possible explanations. J Cataract Refract Surg 2005;31(5):1074–1075.

Oral D, Awwad ST, Seward MS, Bowman RW, McCulley JP, Cavanagh HD. Hyperopic laser in situ keratomileusis in eyes with previous radial keratotomy. J Cataract Refract Surg 2005;31(8):1561–1568.

Orthopaedic Surgery and Physical Medicine and Rehabilitation

Borer DS, Starr AJ, Reinert CM, Rao AV, Weatherall P, Thompson D, Champine J, Jones AL. The effect of screening for deep vein thrombosis on the prevalence of pulmonary embolism in patients with fractures of the pelvis or acetabulum: a review of 973 patients. J Orthop Trauma 2005;19(2):92–95.

Bosse MJ, McCarthy ML, Jones AL, Webb LX, Sims SH, Sanders RW, MacKenzie EJ; The Lower Extremity Assessment Project (LEAP) Study Group. The insensate foot following severe lower extremity trauma: an indication for amputation? J Bone Joint Surg Am 2005;87(12):2601–2608.

Brodsky JW, Baum BS, Pollo FE, Shabat S. Surgical reconstruction of posterior tibial tendon tear in adolescents: report of two cases and review of the literature. Foot Ankle Int 2005;26(3):218–223.

Brodsky JW, Passmore RN, Pollo FE, Shabat S. Functional outcome of arthrodesis of the first metatarsophalangeal joint using parallel screw fixation. Foot Ankle Int 2005;26(2):140–146.

Brodsky JW, Seidenfeld SM, Brooks B, Shabat S. Aspergillus osteomyelitis and lymphangitis in immunocompromised patient after toenail clipping. Foot Ankle Int 2005;26(7):576–578.

DeYoe BE, Wood J. The Evans calcaneal osteotomy. Clin Podiatr Med Surg North Am 2005;22(2):265–276, vi.

Duffy FJ Jr, Brodsky JW, Royer CT. Preliminary experience with perforator flaps in reconstruction of soft-tissue defects of the foot and ankle. Foot Ankle Int 2005;26(3):191–197.

Flatt AE. The troubles with pinkies. Proc (Bayl Univ Med Cent) 2005;18(4):341–344.

Flatt AE. Webbed fingers. Proc (Bayl Univ Med Cent) 2005;18(1):26–37.

Jackson RW. Arthritis degenerativa.In McGinty JB, Burkhart SS, Johnson DH, Richmond JC, Jackson RW, eds. Artroscopia Quirùrgica, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2005:316–322.

Jackson RW. Historia de la artroscopia. In McGinty JB, Burkhart SS, Johnson DH, Richmond JC, Jackson RW, eds. Artroscopia Quirùrgica, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2005:3–7.

Jackson RW, McGinty JB. Ética. In McGinty JB, Burkhart SS, Johnson DH, Richmond JC, Jackson RW, eds. Artroscopia Quirùrgica, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2005:8–10.

Lee D, Dauphinee DM. Morphological and functional changes in the diabetic peripheral nerve: using diagnostic ultrasound and neurosensory testing to select candidates for nerve decompression. J Am Podiatr Med Assoc 2005;95(5):433–437.

MacKenzie EJ, Bosse MJ, Pollak AN, Webb LX, Swiontkowski MF, Kellam JF, Smith DG, Sanders RW, Jones AL, Starr AJ, McAndrew MP, Patterson BM, Burgess AR, Castillo RC. Long-term persistence of disability following severe lower-limb trauma. Results of a seven-year follow-up. J Bone Joint Surg Am 2005;87(8):1801–1809.

Roberts CS, Pape HC, Jones AL, Malkani AL, Rodriguez JL, Giannoudis PV. Damage control orthopaedics: evolving concepts in the treatment of patients who have sustained orthopaedic trauma. Instr Course Lect 2005;54:447–462.

Otolaryngology

Adelson RT, DeFatta RJ, Miles BA, Hoblitt SL, Ducic Y. Metastatic breast cancer of the oral cavity. Am J Otolaryngol 2005;26(4):279–281.

Adelson RT, Ducic Y. Metastatic head and neck carcinoma to a percutaneous endoscopic gastrostomy site. Head Neck 2005;27(4):339–343.

Athre R, Ducic Y. Frontal sinus hamartomas. Am J Otolaryngol 2005;26(6):419–421.

Athre RS, Vories A, Mudrovich S, Ducic Y. Osteosarcomas of the larynx. Laryngoscope 2005;115(1):74–77.

Ducic Y, Adelson R. Use of the endoscopic forehead-lift to improve brow position in persistent facial paralysis. Arch Facial Plast Surg 2005;7(1):51–54.

Ducic Y, Athre R, Cochran CS. The split orbicularis myomucosal flap for lower lip reconstruction. Arch Facial Plast Surg 2005;7(5):347–352.

Ducic Y, Oxford LE. Use of precontoured positioning plates and pericranial flaps in midfacial reconstruction to optimize aesthetic and functional outcomes. Arch Facial Plast Surg 2005;7(6):387–392.

Oxford LE, Ducic Y. Elective transcervical superior mediastinal lymph node dissection for advanced laryngeal and level 4 N3 squamous cell carcinoma. Laryngoscope 2005;115(4):625–628.

Oxford L, Ducic Y. Use of fibula-free tissue transfer with preoperative 2-vessel runoff to the lower extremity. Arch Facial Plast Surg 2005;7(4):261–264.

Potter JK, Ducic Y, Ellis E III. Extended bilaminar forehead flap with cantilevered bone grafts for reconstruction of full-thickness nasal defects. J Oral Maxillofac Surg 2005;63(4):566–570.

Smith JE, Ducic Y, Adelson R. The utility of the temporalis muscle flap for oropharyngeal, base of tongue, and nasopharyngeal reconstruction. Otolaryngol Head Neck Surg 2005;132(3):373–380.

Verret DJ, Defatta R, Ducic Y. Transorbital penetration of the skull base with an occult foreign body. Am J Emerg Med 2005;23(7):901–902.

Verret DJ, Ducic Y, Oxford L, Smith J. Hydroxyapatite cement in craniofacial reconstruction. Otolaryngol Head Neck Surg 2005;133(6):897–899.